DINAMIQS welcomes new CEO

Martin joins from Rentschler Biopharma SE, where he was Chief Transformation Officer and previously CEO of Rentschler’s US biopharma business and operations. Prior to that, Martin led McKinsey’s medical products operations service line in Europe, working with leading life science companies across strategy, operations and R&D.

Martin’s experience in growing businesses and driving transformations will further help building DINAMIQS into a leading CDMO in the Cell & Gene Therapy space.